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Advance Access publication 31 May 2007 Rapid decrease in the prevalence of macrolideresistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain) Sir, An increase in erythromycin resistance rates among group A streptococci (GAS) has been reported in some European countries, including Spain, where in some regions the level of resistance is very high (62.3%). 1 Resistance to erythromycin is commonly caused by the presence of an active drug efflux pump (M phenotype) or due to target site modification by inducible or constitutive methylases (MLS B phenotype).
It is well established that the prevalence of resistance to antimicrobials depends in part on their use in the community. 2 In the case of GAS, a nationwide study in Finland indicated that a reduction in macrolide use correlated with a decrease in macrolide resistance. 3 In contrast with this idea, between 2002 and 2004 there were no relevant variations in the attended population or in the consumption of macrolides in Cantabria (Spain), however, we noted a marked decrease in macrolide-resistant GAS in January-April 2004. This study was undertaken to determine the reasons for this rapid decrease.
Antibiotic consumption data from January 2002 to April 2004 were obtained from SIFARCAN (Pharmaceutical Information System of Cantabria). All GAS collected from January 2002 to April 2004 at the Hospital Marques de Valdecilla of Cantabria (Spain) were identified by conventional methods. More than 95% of these isolates were from pharyngotonsillitis. Susceptibility of isolates to macrolides during this period was routinely tested by disc diffusion according to the CLSI guidelines and phenotypes of resistance were evaluated as previously described. 4 The prevalence of GAS resistant to macrolides in Cantabria Figure 1 ). However, a sudden decrease in the frequency of erythromycin-resistant strains was observed suggesting the emergence and dissemination of some susceptible strains.
For this purpose, we monitored by emm gene typing, following the protocol previously described, 4 the diversity of all GAS isolated during April 2004 at the same hospital (94 isolates; 11 from adult patients and 83 from paediatric patients). All were susceptible to macrolides and caused acute pharyngotonsillitis. It was proved that, emm type 1 and emm type 3 were the most prevalent emm types among GAS isolates susceptible to erythromycin. Besides these emm types, all the other emm types were represented by few isolates. emm type 1 and emm type 3 are the most frequent in Spain, however, the frequency of these emm types was very high (43% emm type 1 and 34% emm type 3) when compared with a previous study (12.4% and 11.4%, respectively). 4 For this reason, we investigated whether these emm type 1 and emm type 3 isolates represented only few clones.
Genotypic characterization of the 94 GAS isolates obtained during April 2004 was carried out by genomic DNA macrorestriction with SfiI and PFGE following the protocol described previously. 4 All emm type 1 and emm type 3 isolates exhibited the same PFGE patterns, respectively. These results suggest that all emm type 1 and emm type 3 isolates collected from different patients in April 2004 in Cantabria represented only two different clones. Furthermore, it is likely that the rapid decrease in the frequency of the macrolide-resistant GAS isolates was caused by the emergence and successful dissemination of these GAS isolates susceptible to erythromycin.
In summary, we have shown that, without changes in the consumption of macrolides, the frequency of macrolide-resistant GAS in a particular geographical area may be significantly altered by the emergence of successful epidemic clones susceptible to these antimicrobial agents. This indicates that additional studies, including molecular analysis of genes involved in resistance and of clonal relationship of isolates, are required to establish a cause-effect between consumption and resistance. Sir, Pseudomonas aeruginosa is one of the leading causes of nosocomial infections. Initiation of antimicrobial therapy is often empirical; therefore, it is important to know the susceptibility profile of pathogens in order to select the most appropriate antibiotic. This underscores the importance of using current surveillance data in order to develop rational empirical antimicrobial therapy recommendations. 1 The aim of this study was to carry out surveillance of antimicrobial susceptibility of P. aeruginosa clinical isolates in Centro Hospitalar de Coimbra (CHC) to ascertain resistance patterns in order to assist in the determination of guidelines for empirical regimens and prompt enforcement of infection control measures. CHC is a 600 bed, central hospital comprising a general, maternity and paediatric hospital, situated in the centre of Portugal, a highly populated region.
The collection period was from April 2003 to April 2006, and only one isolate per patient was included. Isolates were from inpatients with community-acquired infections (n ¼ 414) or nosocomial infections (n ¼ 685).
Identification and determination of antimicrobial susceptibilities were performed in CHC using MicroScan WalkAway (Dade Behring) and CLSI (formerly NCCLS) breakpoints.
